Study to Find Maintenance Dose for Periodic Administration of ASP3550

Clinical trial NCT01261572 · COMPLETED

Trial details

NCT number: NCT01261572
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2010-10-12
Primary completion: 2012-04-24
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.